Literature DB >> 17210840

Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig.

Leo Timmers1, Joost P G Sluijter, Cees W J Verlaan, Paul Steendijk, Maarten Jan Cramer, Maringa Emons, Chaylendra Strijder, Paul F Gründeman, Siu Kwan Sze, Lin Hua, Jan J Piek, Cornelius Borst, Gerard Pasterkamp, Dominique P V de Kleijn.   

Abstract

BACKGROUND: Cyclooxygenase (COX)-2 expression in the heart increases after myocardial infarction (MI). In murine models of MI, COX-2 inhibition preserves left ventricular dimensions and function. We studied the effect of selective COX-2 inhibition on left ventricular remodeling and function after MI in a pig model. METHODS AND
RESULTS: Twenty-two pigs were assigned to COX-2 inhibition with a COX-2 inhibitor (COX-2i; celecoxib 400 mg twice daily; n=14) or a control group (n=8). MI was induced by left circumflex coronary artery ligation, and the animals were euthanized 6 weeks later. Cardiac dimensions and function were assessed with echocardiography and conductance catheters. Infarct size and collagen density were analyzed with triphenyltetrazolium chloride staining and picrosirius red staining, respectively. COX-2 inhibition increased mortality compared with controls (50% versus 0%, P=0.022), whereas infarct size was similar (13.1+/-0.7% versus 14.1+/-0.1%, P=0.536). The decrease in thickness of the infarcted myocardial wall was more pronounced in the COX-2i group (60.6+/-9.6% versus 36.2+/-5.7%, P=0.001). End-diastolic volume was higher in the COX-2i group (133.9+/-33.5 versus 91.1+/-24.0 mL; P=0.021), as was the end-systolic volume at 100 mm Hg (81.7+/-27.8 versus 56.3+/-21.1 mL; P=0.037), which indicates that systolic function was more severely impaired. Infarct collagen density was lower after COX-2i treatment (25.3+/-3.9 versus 56.1+/-23.8 gray value/mm2; P=0.005).
CONCLUSIONS: In pigs, COX-2 inhibition after MI is associated with increased mortality, enhanced left ventricular remodeling, and impaired systolic function, probably due to decreased infarct collagen fiber density.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17210840     DOI: 10.1161/CIRCULATIONAHA.106.647230

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

1.  Compensatory hypertrophy induced by ventricular cardiomyocyte-specific COX-2 expression in mice.

Authors:  John M Streicher; Kenichiro Kamei; Tomo-o Ishikawa; Harvey Herschman; Yibin Wang
Journal:  J Mol Cell Cardiol       Date:  2010-02-17       Impact factor: 5.000

Review 2.  Pleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly.

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2008-02-07       Impact factor: 4.214

3.  Competitive enzymatic interactions determine the relative amounts of prostaglandins E2 and D2.

Authors:  Rui Yu; Lei Xiao; Guiqing Zhao; John W Christman; Richard B van Breemen
Journal:  J Pharmacol Exp Ther       Date:  2011-08-24       Impact factor: 4.030

4.  Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2.

Authors:  Kyriakos N Papanicolaou; John M Streicher; Tomo-O Ishikawa; Harvey Herschman; Yibin Wang; Kenneth Walsh
Journal:  J Mol Cell Cardiol       Date:  2010-04-24       Impact factor: 5.000

5.  Remodelling and adverse remodelling in CAD.

Authors:  S Brenner; G Ertl
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

6.  The effects of cyclooxygenase and nitric oxide synthase inhibition on oxidative stress in isolated rat heart.

Authors:  Nevena Barudzic; Drenka Turjacanin-Pantelic; Vladimir Zivkovic; Dragica Selakovic; Ivan Srejovic; Jovana Joksimovic; Jovana Jakovljevic; Dragan M Djuric; Vladimir Lj Jakovljevic
Journal:  Mol Cell Biochem       Date:  2013-06-09       Impact factor: 3.396

7.  Surgical left ventricular radius enlargement by patch insertion on the beating heart: a new experimental aneurysm model.

Authors:  Paul F Gründeman; Tycho I G van der Spoel; Paul Steendijk; Frebus van Slochteren; Maarten Jan M Cramer; Pieter A Doevendans; Gerard Pasterkamp
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-04-19

Review 8.  Ca2+ regulatory mechanisms of exercise protection against coronary artery disease in metabolic syndrome and diabetes.

Authors:  Michael Sturek
Journal:  J Appl Physiol (1985)       Date:  2011-05-19

Review 9.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

10.  Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.

Authors:  Zo Rakotoniaina; Pascal Guerard; Frédéric Lirussi; Luc Rochette; Monique Dumas; Françoise Goirand; Marc Bardou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.